Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

Follow updates as Donald Trump Cabinet picks Linda McMahon, Robert Kennedy and Kash Patel face Senate proceedings. The ...

The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...

According to the World Health Organization (WHO), over 22% of the global population smokes, with more than 9 million ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

FDA Approves First ... Charles Argoff of the Albany Medical Center in New York, who consulted for Vertex on the drug’s development, told the Associated Press. The approval marks the first ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Journey Medical, a specialty pharmaceutical company, focuses on dermatology and has achieved cashflow breakeven with its current $55mm-$60mm revenue and sales infrastructure. The FDA-approved ...

Charles Argoff of the Albany Medical Center, who consulted for Vertex on the drug's development ... Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning ...